Halozyme Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $66k | 64k | 1.04 |
| 2025-06-30 | $1.8M | 1.9M | 0.99 |
| 2023-06-30 | $7.5k | 9.0k | 0.83 |
| 2023-03-31 | $5.1k | 6.0k | 0.85 |